Advertisement
Screener

ImmuCell Corporation (ICCC) Accounts Payable and Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

ImmuCell Corporation Accounts Payable and Accrued Liabilities

ImmuCell Corporation (ICCC) had Accounts Payable and Accrued Liabilities of $0 as of 2025-06-30, per its 10-Q filed 2025-08-14.

Financial Statements › Balance Sheet › Liabilities

us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2025-08-14

  • 2025-06-30: Accounts Payable and Accrued Liabilities $0.00.
  • 2025-03-31: Accounts Payable and Accrued Liabilities $0.00.
  • 2024-12-31: Accounts Payable and Accrued Liabilities $300.00K.
  • 2024-09-30: Accounts Payable and Accrued Liabilities $275.00K.
Period endAccounts Payable and Accrued Liabilities
2025-06-30$0.00
10-Q · filed 2025-08-14
2025-03-31$0.00
10-Q · filed 2025-05-14
2024-12-31$300.00K
10-Q · filed 2025-08-14
2024-09-30$275.00K
10-Q · filed 2024-11-13
2024-06-30$250.00K
10-Q · filed 2024-08-13
2024-03-31$225.00K
10-Q · filed 2024-05-14
2023-12-31$200.00K
10-K · filed 2025-03-28
2023-09-30$175.00K
10-Q · filed 2023-11-13
2022-12-31$100.00K
10-K · filed 2024-04-01
2016-12-31$1.89M
10-K · filed 2017-03-30
2016-09-30$888.86K
10-Q · filed 2016-11-10
2016-06-30$963.74K
10-Q · filed 2016-08-11
2016-03-31$761.74K
10-Q · filed 2016-05-11
2015-12-31$662.16K
10-K · filed 2017-03-30
2015-09-30$545.93K
10-Q · filed 2015-11-12
2015-06-30$503.83K
10-Q · filed 2015-08-13
2015-03-31$587.19K
10-Q · filed 2015-05-12
2014-12-31$851.68K
10-K · filed 2016-03-25
2013-12-31$445.23K
10-K · filed 2015-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92